Jasper Kurth joined Thor Medical ASA as CEO in August 2024. Previously, he served as General Manager for Bayer's Radiology division in the Nordic markets, based out of Stockholm, Sweden. Throughout his career at Bayer, Jasper has gained extensive experience in both strategy and operations across various divisions, including a tenure at Bayer's corporate headquarters in Leverkusen, Germany. Jasper holds a master's-equivalent degree in Business Information Management. He is married and has two young children. Number of shares: 0 Number of options: 3 600 000

Brede Ellingsæter joined Thor Medical as CFO in July 2023. Prior to Thor Medical he was the CFO in Scatec Innovation. Ellingsæter has also had an extensive career in Elkem ASA, where he held several various senior positions including CFO of Carbon Solutions division during his 8 years with the company. Ellingsæter holds a Master of Business and Economics from Norwegian School of Economics (NHH). Number of shares: 0 Number of options: 3 100 000

Dr. Alf Bjørseth has a long track record of establishing new companies based on proprietary developed technologies, primarily within the areas of renewable energy and advanced materials. His efforts have resulted in a number of new businesses like REC, NorSun, Scatec Solar ASA, Norsk Titanium and REEtec AS. He will be best know for having founded ScanWafer in 1994, followed by other companies within the solar industry, all merged into Renewable Energy Corporation in 2000 where he served as President and CEO until the fall of 2005. Alf Bjørseth holds a Doctor Phil. in physical chemistry from the University of Oslo. He started his career as a researcher and were Corporate Director of Research at Norsk Hydro and Director of Technology for Elkem.

Hassfjell holds an M.Sc. 1992 and D.Sc. 1997 in nuclear chemistry from University of Oslo (UiO). He has more than 30 years’ experience in nuclear and radiochemistry scientific research with experience of all radioactivity levels (A, B, C-lab) with several alpha- and beta-emitters from radionuclide production to development of radiopharmaceuticals and preclinical testing. Hassfjell has been scientist and project leader at IFE and Director of generator development for ARTBIO before joining Thor Medical. His career also include Post Doc at UiO, NIH and University of Chicago (USA) developing production methods for alpha emitters and microdosimetric methodology. Number of shares: 0; Number of options: 2 700 000

Astrid Liland joined Thor Medical on 1 January 2024 as VP EHS. Before joining Thor Medical, she was Director of nuclear emergency and response at the Norwegian radiation and nuclear safety authority (DSA). Liland has 25 years’ experience in radiation research, environmental radioactivity, radioactive contamination and consequences for man and the environment. She has been active in the nuclear scientific research community through many national, Nordic, European and international research projects. Liland holds a Master of Science in nuclear chemistry from the University of Oslo (UiO). Number of shares: 0 Number of options: 2 100 000